Cargando…

Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma

As a member of the Eph family of receptor tyrosine kinases, EphA7 plays an important role in cancer. However, the expression and significance of Eph receptors in esophageal squamous cell carcinoma (ESCC) remain unclear. Here, we detected the expression of EphA7 by immunohistochemistry in a sample of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yu-Qin, Zhang, Jun-Yi, Bai, Chun-Ying, Xu, Xiu-E, Wu, Jian-Yi, Chen, Bo, Wu, Zhi-Yong, Wang, Shao-Hong, Shen, Jian, Shen, Jin-Hui, Yao, Xiao-Dong, Gao, Lian-Zhu, Wu, Bao, Gu, Hong-Li, Liu, Xiao-Hui, Li, Xin, Li, En-Min, Xu, Li-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY 2015
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491497/ https://www.ncbi.nlm.nih.gov/pubmed/26160986 http://dx.doi.org/10.1267/ahc.14054

Ejemplares similares

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway
por: Xiang, Yi-Ping, et al.
Publicado: (2020)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015)

High EphA2 protein expression in renal cell carcinoma is associated with a poor disease outcome
por: XU, JINSHENG, et al.
Publicado: (2014)

PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma via Modulation of EphA2 Expression
por: Han, Xiao, et al.
Publicado: (2021)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
por: Li, Shibao, et al.
Publicado: (2017)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
por: Cui, Shuang, et al.
Publicado: (2021)

The relationship between miR-302b and EphA2 and their clinical significance in gastric cancer
por: Tang, Lanhua, et al.
Publicado: (2018)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

Antitumor Effects of Oncolytic Adenovirus-Carrying siRNA Targeting Potential Oncogene EphA3
por: Zhao, Yali, et al.
Publicado: (2015)

The role of prostaglandin E receptor 2 and epidermal growth factor receptor in esophageal squamous cell carcinoma patients with (pN+) regional lymph node metastasis
por: Luo, Hui-Qin, et al.
Publicado: (2019)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis
por: Li, Qi-Guang, et al.
Publicado: (2020)

Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
por: Herath, N I, et al.
Publicado: (2009)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

EphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy
por: Feng, Li, et al.
Publicado: (2017)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis
por: Cao, Hui-Hui, et al.
Publicado: (2014)

Antitumor activity of the third generation EphA2 CAR-T cells against glioblastoma is associated with interferon gamma induced PD-L1
por: an, Zhijing, et al.
Publicado: (2021)

A three-protein signature and clinical outcome in esophageal squamous cell carcinoma
por: Cao, Hui-Hui, et al.
Publicado: (2014)

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015)

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
por: Yi, Zhongzhen, et al.
Publicado: (2018)

TR(4) nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression
por: Jin, Ren’an, et al.
Publicado: (2018)

Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients
por: Tan, Hua-Zhen, et al.
Publicado: (2016)

EphA8 is a prognostic marker for epithelial ovarian cancer
por: Liu, Xiaoqin, et al.
Publicado: (2016)

High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Lin, Ching-Yih, et al.
Publicado: (2017)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
por: Dong, Xiao-Dong, et al.
Publicado: (2023)

EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway
por: Zhao, Xinyue, et al.
Publicado: (2022)

SORLA attenuates EphA4 signaling and amyloid β–induced neurodegeneration
por: Huang, Timothy Y., et al.
Publicado: (2017)

Anlotinib Inhibits Tumor Angiogenesis and Promotes the Anticancer Effect of Radiotherapy on Esophageal Cancer through Inhibiting EphA2
por: Gu, Zhenlin, et al.
Publicado: (2022)

EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
por: CHEN, PEIJIE, et al.
Publicado: (2014)

Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes
por: Li, Qun, et al.
Publicado: (2013)

EphA kinase activation regulates HGF-induced epithelial branching morphogenesis
por: Miao, Hui, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_k0uqafq39vg0sj6fr7cccc0s13